NASDAQ:ACOR
Acorda Therapeutics Stock News
$0.661
+0 (+0%)
At Close: May 09, 2024
Cleaners risk health to work during pandemic, then lose jobs
07:23pm, Friday, 01'st May 2020
Lissette Serrano asked for a mask while she did her job cleaning toilets and picking up trash at a busy rest stop on a Connecticut parkway. When she told her boss she could not leave home, Serrano sa
Risau vaksin masih tiada, ini 3 ubat sedia ada terbaik berpotensi rawat Covid-19
11:00pm, Thursday, 30'th Apr 2020
Ubat malaria, chloroquine atau hydroxychloroquine- berpotensi jadi ubat terbaik rawat Covid-19.
The Michael J. Fox Foundation Releases New Video Resource to Empower Patients and Families to Participate in Critical Parkinson's Research
12:50pm, Wednesday, 29'th Apr 2020
The Michael J. Fox Foundation for Parkinson's Research (MJFF) has released a new video, "Together, We Can Solve the Parkinson's Puzzle," to illustrate the role each individual within a family and comm
Relmada Therapeutics, Inc. (Nasdaq: RLMD), a clinical-stage company developing novel therapies for the treatment of central nervous system (CNS) diseases, today announced the appointment of Brian A. W
Acorda First Quarter 2020 Update: Webcast/Conference Call Scheduled for May 5, 2020
11:00am, Tuesday, 28'th Apr 2020
Acorda Therapeutics, Inc. (NASDAQ: ACOR) will host a conference call and webcast in conjunction with its first quarter 2020 update and financial results on Tuesday, May 5 at 4:30 p.m. ET.
Contrasting Atara Biotherapeutics (NASDAQ:ATRA) & Acorda Therapeutics (NASDAQ:ACOR)
06:58am, Tuesday, 28'th Apr 2020
Atara Biotherapeutics (NASDAQ:ATRA) and Acorda Therapeutics (NASDAQ:ACOR) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the streng
BioCryst Pharmaceuticals (NASDAQ:BCRX) vs. Acorda Therapeutics (NASDAQ:ACOR) Critical Survey
05:42am, Sunday, 26'th Apr 2020
BioCryst Pharmaceuticals (NASDAQ:BCRX) and Acorda Therapeutics (NASDAQ:ACOR) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the st
Bank of New York Mellon Corp Has $1.10 Million Position in Acorda Therapeutics Inc (NASDAQ:ACOR)
08:20am, Saturday, 25'th Apr 2020
Bank of New York Mellon Corp lessened its position in Acorda Therapeutics Inc (NASDAQ:ACOR) by 38.6% in the fourth quarter, Holdings Channel.com reports. The firm owned 541,307 shares of the biopharma
Acorda (ACOR) to Report Q1 Earnings: What's in the Cards?
03:49pm, Friday, 24'th Apr 2020
During Acorda's (ACOR) upcoming Q1 earnings call, investor focus will be on the sales uptake of its newly-launched Parkinson's disease drug, Inbrija.
Acorda (ACOR) to Report Q1 Earnings: What's in the Cards?
03:49pm, Friday, 24'th Apr 2020
During Acorda's (ACOR) upcoming Q1 earnings call, investor focus will be on the sales uptake of its newly-launched Parkinson's disease drug, Inbrija.
Russo Partners' Sports-Health Alliance, part of the New York City-based healthcare and technology communications firm, has launched "Stay Safe. Stay Together. Stay Healthy," a social media campaign to
US Sleep-Wake Disorder Market (2019 to 2025) - Featuring Aeroflow, Arena Pharmaceuticals & Acorda Therapeutics Among Others
10:08am, Thursday, 23'rd Apr 2020
Dublin, April 23, 2020 -- The "US Sleep-Wake Disorder Market 2019-2025" report has been added to ResearchAndMarkets.com's offering. The US sleep-wake.
Multiple Sclerosis Drugs Industry Assessment 2020: Immunomodulators, Immunosuppressants, Interferons and Others
02:45pm, Tuesday, 21'st Apr 2020
The "Multiple Sclerosis Drugs Market Global Report 2020" report has been added to ResearchAndMarkets.com's offering.
European Respiratory Devices Market 2020 by Product, End-user and Region - ResearchAndMarkets.com
08:27am, Tuesday, 21'st Apr 2020
Press release content from Business Wire. The AP news staff was not involved in its creation.
